Figure 1.
PPAR agonists, their PPAR target(s) and current status in clinical pipeline. Drugs with strikethrough mark (e.g., PPAR agonist) have been discontinued at clinical or preclinical stages.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.